4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-23-069455
Options or other derivatives
- Director acquired 16,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fairmount Funds Management LLC · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-07 | Grant or award : show line 1 in the form Series B Preferred Stock | +16,667 | $600.00 | $10,000,200 | 16,667 | I |
Loading xslF345X05/ownership.xml…